Sleep: £ 648 An anti-snoring device that zooms your TONGUE can reduce snores by a fifth

Does your partner spin like a circular saw? Help can be available from a device that can reduce by a fifth by delivering electrical currents to the wearer’s tongue.

The eXciteOSA unit doesn’t actually zap the wearer while they sleep as a punishment for snoring (as attractive as that may seem to some long-suffering sleepers !)

Instead, the device from London-based Signifier Medical Technologies is worn for daytime sessions, and stimulates the muscles in the mouth and tongue.

Snoring is caused by the shaking of neck structures, which relax while sleeping, restricting the passage and creating a noisy air disturbance.

Strengthening tongue muscles, however, helps the respiratory tract to stay open at night, allowing for a quieter night for the wearer and those inside ears.

The eXciteOSA device is already on sale in the UK for £ 648 and will sell in the US for $ 750.

Scroll down for video

Does your partner spin like a circular saw? Assistance can be available from a device, pictured in use, which can reduce by a fifth by delivering electrical currents to the wearer’s tongue.

The eXciteOSA unit doesn't actually zap the wearer while they sleep as a punishment for snoring (as attractive as that may seem to some long-suffering sleepers !).  Instead, the device from London-based Signifier Medical Technologies is worn for daytime sessions, and stimulates the muscles in the mouth and tongue.

The eXciteOSA unit doesn’t actually zap the wearer while they sleep as a punishment for snoring (as attractive as that may seem to some long-suffering sleepers !). Instead, the device from London-based Signifier Medical Technologies is worn for daytime sessions, and stimulates the muscles in the mouth and tongue

HOW EXCITEOSA HELPS TACKLE SNORING AND SLEEP APNEA

EXciteOSA can also help with mild sleep apnea – a condition where a person’s airways can become completely blocked at night, disrupting normal breathing.

If left untreated, sleep apnea can increase the risk of cancer, glaucoma, heart attacks, high blood pressure, strokes, type 2 diabetes and mental and behavioral disorders.

‘We are delighted to launch the first day-to-day treatment center for the treatment of primary obstructive sleep apnea and snoring,’ said Akhil Tripathi, CEO & Co-Founder of Signifier Medical Technologies.

‘Not only does our patented smart device, eXciteOSA, handle the root cause of the problem, but it also doesn’t require an overnight wear device for peaceful sleep.’

The Bluetooth-enabled device, controlled by an app, is like a kind of mouth guard on a stick, and is worn to sit around the tongue, and has four electrodes that stimulate the top of the tongue and the surfaces low.

Snorers are encouraged to use eXciteOSA during the day for 20 minutes daily for the first six weeks and then once a week thereafter.

During each session, the electrons stimulate the muscles of the tongue using a series of electric pulses, each lasting a few seconds, with similar rest periods in between.

‘The stimulus does not hurt and the patient has a choice to set and change the level of treatment they want,’ a Signifier Medical Technologies spokesperson said.

The company said eXciteOSA has served more than 2,000 users – mostly in the UK.

The eXciteOSA device (pictured) from London-based Signifier Medical Technologies is worn for daytime sessions, and stimulates the muscles in the mouth and tongue

The eXciteOSA device (pictured) from London-based Signifier Medical Technologies is worn for daytime sessions, and stimulates the muscles in the mouth and tongue

The eXciteOSA is already on sale in the UK for £ 648 and will sell in the US for $ 750. Pictured: the device in its case

The device responds around the tongue (as seen)

The eXciteOSA is already on sale in the UK for £ 648 and will sell in the US for $ 750. Pictured: the device (left, case) fits around the tongue (as seen, right)

The eXciteOSA device was approved for marketing to American adults as a prescription-only device earlier this month by the U.S. Food and Drug Administration (FDA) Center for Radical Equipment and Health.

‘Obstructive sleep apnea not only affects sleep quality, but can have other adverse health effects if left untreated,’ said FDA director at the Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Instruments , Malvina Eydelman.

In tests, FDA experts found that a course of using the eXciteOSA device reduced snoring at levels above 40 decibels – as high as bird calls – by more than 20 percent in 87 of 115 patients.

In a subset of patients who suffered from moderate obstruction snoring and sleep apnea, meanwhile, the team observed an average 48 percent reduction in the number of times of shallow breathing per hour , from 10.2 to 5.3, in 41 out of 48 patients.

The Bluetooth-enabled device, controlled by an app – which looks like a kind of guard on a stick, and is worn to sit around the tongue – has four electrodes that stimulate the top of the tongue and the lower surfaces. Pictured: The My eXciteOSA app interface

Snorers are encouraged to use eXciteOSA (pictured) during the day for 20 minutes daily for the first six weeks and then once a week thereafter.  During each session, the electrons stimulate the muscles of the tongue using a series of electric pulses, each lasting a few seconds, with similar rest periods in between.

During each session, the electrons stimulate the muscles of the tongue (pictured) using a series of electric pulses, each lasting a few seconds, with similar rest periods in between.

Snorers are encouraged to use eXciteOSA (left) during the day for 20 minutes daily for the first six weeks and then once a week thereafter. During each session, the electrons stimulate the muscles of the tongue (right) using a series of electric pulses, each lasting a few seconds, with similar rest periods in between.

‘Today’ s authorization offers a new option for thousands of people who experience snoring or mild sleep apnea, ‘said Dr Eydelman.

EXciteOSA is not suitable, however, for patients with pacemakers or packaged lead, implants, dental implants, dental implants, metal oral prosthesis, oral ulcerations or those who are pregnant with a child.

Side effects observed in an FDA study included excessive salivation, tongue or tooth discomfort, tongue tingling, sensitivity of dental fillings, metabolic taste, gagging and tight jaws.

WHAT IS AN OBSTRUCTIVE SLEEP APNEA?

Obstructive sleep apnea (OSA) occurs when a person’s neck walls relax and narrow during sleep, obstructing their airways.

This disrupts normal breathing, with symptoms including loud snoring, noisy and labored breathing, and repeated times when breathing is accompanied by gasping and snorting.

OSA affects between four and 10 per cent of people in the UK. In the US, it affects about 22 million.

In a program, a lack of oxygen causes a victim’s brain to take them out of deep sleep to open their airways.

These persistent sleep disturbances can make a person very tired, often unaware of the problem.

Risks for OSA include:

  • Being obese – too much body fat increases the amount of soft tissue in the neck
  • Being male
  • Being 40 or older
  • Do you have a big neck
  • Drinking too much alcohol
  • Being in menopause – hormonal changes cause the neck muscles to relax

Treatment includes lifestyle changes, such as losing weight, if necessary, and avoiding alcohol.

In addition, advanced air pressure devices (CPAP) prevent airway closure by delivering a continuous supply of compressed air through a mask.

A mandibular advancement device (MAD) can also be used, which is like a gum shield that holds the hook and tongue forward to increase the area at the back of the neck.

Without treatment, OSA increases a person ‘s risk of high blood pressure, stroke, heart attack and type 2 diabetes.

Source: NHS

.Source